Glofitamab
CAS: 2229047-91-8
Ref. 3D-FG184074
| 1mg | 1,062.00 € | ||
| 5mg | 3,540.00 € | ||
| 10mg | 5,663.00 € | ||
| 25mg | 10,618.00 € | ||
| 50mg | 15,927.00 € |
Product Information
Glofitamab is a bispecific monoclonal antibody that binds to both CD20 and CD3 surface antigens found on B- and T-cells, respectively. It has a 2:1 configuration, with bivalency towards CD20 and monovalency towards CD3. By binding to both CD20 and CD3, it creates an immunological synapse that serves to recruit T-cells to CD20-expressing B-cells. This leads to T-cell activation and proliferation, secretion of cytokines, and the lysis of CD20-expressing B cells even under low effector-to-target cell ratios. Glofitamab is used for the treatment of diffuse large B-cell lymphoma.
This is a product for research use only.
Chemical properties
Technical inquiry about: 3D-FG184074 Glofitamab
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
